High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
219.22M
+47.32%
-0.413
-1.67%
242.34M
+60.28%
-0.559
-35.03%
273.66M
+66.76%
-0.520
-13.33%
Estimates Revision
The market is revising Upward the revenue expectations for Lemonade, Inc. (LMND) for FY2025, with the revenue forecasts being adjusted by 2.17% over the past three months. During the same period, the stock price has changed by 52.84%.
Revenue Estimates for FY2025
Revise Upward
+2.17%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-9.74%
In Past 3 Month
Stock Price
Go Up
+52.84%
In Past 3 Month
6 Analyst Rating
Wall Street analysts forecast LMND stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LMND is 52.20 USD with a low forecast of 33.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
3 Hold
2 Sell
Hold
Current: 76.800
Low
33.00
Averages
52.20
High
80.00
Current: 76.800
Low
33.00
Averages
52.20
High
80.00
Keefe Bruyette
Underperform
maintain
$35 -> $40
2025-11-25
Reason
Keefe Bruyette
Price Target
$35 -> $40
2025-11-25
maintain
Underperform
Reason
Keefe Bruyette raised the firm's price target on Lemonade to $40 from $35 and keeps an Underperform rating on the shares. The firm sees modest downside to consensus estimates in 2026, the analyst tells investors in a research note.
Citizens JMP
Matthew Carletti
Outperform
maintain
$60 -> $80
2025-11-24
Reason
Citizens JMP
Matthew Carletti
Price Target
$60 -> $80
2025-11-24
maintain
Outperform
Reason
Citizens JMP analyst Matthew Carletti raised the firm's price target on Lemonade to $80 from $60 and keeps an Outperform rating on the shares. Lemonade remains very early in its life cycle and is making significant strides toward building an insurance company that will continue to gain market share and sustain the test of time, the analyst tells investors in a research note.
Morgan Stanley
Underweight
maintain
$49 -> $53
2025-11-17
Reason
Morgan Stanley
Price Target
$49 -> $53
2025-11-17
maintain
Underweight
Reason
Morgan Stanley raised the firm's price target on Lemonade to $53 from $49 and keeps an Underweight rating on the shares. The firm updated models in the insurance space post the Q3 reports. For property and casualty, Morgan Stanley sees a softening cycle heading into 2026, the analyst tells investors.
Morgan Stanley
Underweight
maintain
$45 -> $49
2025-11-10
Reason
Morgan Stanley
Price Target
$45 -> $49
2025-11-10
maintain
Underweight
Reason
Morgan Stanley raised the firm's price target on Lemonade to $49 from $45 and keeps an Underweight rating on the shares.
Piper Sandler
Neutral
maintain
$55 -> $60
2025-09-17
Reason
Piper Sandler
Price Target
$55 -> $60
2025-09-17
maintain
Neutral
Reason
Piper Sandler raised the firm's price target on Lemonade to $60 from $55 and keeps a Neutral rating on the shares. The firm cites increased interest in AI and this is the name to play for the long-term for that. Piper also points out that this is a growth name, which suggests the potential for a true network effect, and notes profitability has improved. On the flip side, the firm acknowledges there has been increased risk exposure, and there is a reliance on direct-to-consumer in a country slow to adopt DTC for insurance purchasing needs historically.
BMO Capital
Jack Matten
Underperform
maintain
$23 -> $42
2025-08-18
Reason
BMO Capital
Jack Matten
Price Target
$23 -> $42
2025-08-18
maintain
Underperform
Reason
BMO Capital analyst Jack Matten raised the firm's price target on Lemonade to $42 from $23 and keeps an Underperform rating on the shares. The firm believes that Lemonade's growth will require less capital vs. personal insurance peers, given its less restricted from a rating agency perspective, the analyst tells investors in a research note. BMO adds that its base-case continues to be that Lemonade will not need a capital raise, though the stock price now reflects a best-case scenario in which Lemonade can scale profitably in highly-competitive auto insurance.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Lemonade Inc (LMND.N) is -39.96, compared to its 5-year average forward P/E of -11.82. For a more detailed relative valuation and DCF analysis to assess Lemonade Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-11.82
Current PE
-39.96
Overvalued PE
-1.92
Undervalued PE
-21.73
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-14.93
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
-0.54
Undervalued EV/EBITDA
-29.32
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
11.17
Current PS
0.00
Overvalued PS
27.95
Undervalued PS
-5.60
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
LMND News & Events
Events Timeline
(ET)
2025-11-05
12:00:03
Lemonade Sees 30.9% Increase
2025-11-05
10:00:06
Lemonade Increases by 20.5%
2025-11-05
06:09:17
Lemonade increases FY25 revenue forecast to $727M-$732M, up from $710M-$715M
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/54b3d7c7dd01b0b0442573a400b164fc938a28fa5db89eb4d3a7f6d1fa5e4b03.png)
Preview
4.5
11-24CNBCJim Cramer's Key 10 Stock Market Insights for Monday
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/bc81f986f59da8b84c88917952f60dda188c81944d632d0016fc878e00d3c28e.png)
Preview
4.0
11-24BenzingaBaidu Expected to Surge Over 69%: 10 Leading Analyst Predictions for Monday
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/default_image/benzinga.png)
Preview
4.0
11-24BenzingaCitizens Upgrades Lemonade to Market Outperform and Increases Price Target to $80
Sign Up For More News
People Also Watch
FAQ
What is Lemonade Inc (LMND) stock price today?
What is Lemonade Inc (LMND)'s business?
What is the price predicton of LMND Stock?
What is Lemonade Inc (LMND)'s revenue for the last quarter?
What is Lemonade Inc (LMND)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Lemonade Inc (LMND)'s fundamentals?
How many employees does Lemonade Inc (LMND). have?